Poloxamer
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2013 (NCT02091596)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetSurfactant
surfactant
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02091596 | Phase 2 | Oct 31, 2013 | Arkios BioDevelopment International, PluroGen Therapeutics |
| NCT02119754 | Phase 2 | Oct 31, 2013 | Arkios BioDevelopment International, PluroGen Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Arkios BioDevelopment International | For profit | 2 | 0 | 1 | 2013 |
| PluroGen Therapeutics | For profit | 2 | 2 | 1 | 2013 |
2 organizations
Page 1 / 1